1056 XTX301, a tumor activated, half-life extended IL-12 promoted potent anti-tumor immunity and activity across multiple syngeneic tumor models
oleh: Wilson Guzman, Damiano Fantini, Parker Johnson, Kurt Jenkins, Hanumantha Rao Madala, Caitlin O’Toole, Magali Pederzoli-Ribeil, Jennifer O’Neil, Jake Taylor, Ekta Patel, Sallyann Vu, Manoussa Fanny, Oleg Yerov, Benjamin Nicholson, Natalia V Malkova, Stephanie Hsiao, Ertan Eryilmaz, Uli Bialucha
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.